摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

邻溴苯乙基溴 | 1074-15-3

中文名称
邻溴苯乙基溴
中文别名
2-(2-溴乙基)-1-溴苯;1-溴-2-(2-溴甲基)苯
英文名称
1-bromo-2-(2-bromoethyl)benzene
英文别名
2-bromophenethyl bromide
邻溴苯乙基溴化学式
CAS
1074-15-3
化学式
C8H8Br2
mdl
——
分子量
263.96
InChiKey
RUGOFYNHMCFJFD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    264℃
  • 密度:
    1.740
  • 闪点:
    126℃

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

安全信息

  • 海关编码:
    2903999090
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    室温

SDS

SDS:e08c23559e709f7c86ad36dfb2bb79bf
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1-bromo-2-(2-bromoethyl)benzene
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1-bromo-2-(2-bromoethyl)benzene
CAS number: 1074-15-3

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H8Br2
Molecular weight: 264.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    邻溴苯乙基溴盐酸氢氧化钾potassium tert-butylate 作用下, 以 乙醇叔丁醇 为溶剂, 生成 2-<2-(2-Bromophenyl)ethyl>-3-methylcyclohex-2-enone
    参考文献:
    名称:
    Highly regioselective 7-endo-aryl radical cyclisation: synthesis of octahydro-2H-dibenzo[a,d]cycloheptenes
    摘要:
    报告了一种高效的7-内源三芳基自由基环化反应,使用三正丁基锡氢化物对烯烃6和乙烯基环己醇11a–d进行反应,生成相应的八氢-2H-二苯[a,d]环庚烯衍生物7、8和12a–d。
    DOI:
    10.1039/c39930000809
  • 作为产物:
    描述:
    邻溴氰苄 在 lithium aluminium tetrahydride 、 双氧水三溴化磷 、 sodium hydroxide 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 25.5h, 生成 邻溴苯乙基溴
    参考文献:
    名称:
    通过路易斯酸催化的 C(sp3)-H 键官能化高度非对映选择性合成四氢萘融合的螺环吲哚
    摘要:
    描述了高度非对映选择性合成的四氢萘稠合螺吲哚衍生物。在回流己烷中用催化量的 Sc(OTf)3 处理亚苄基羟吲哚,以良好的化学产率和优异的非对映选择性(高达 >20:1)得到目标化合物。对反应机理的详细研究表明,两种非对映异构体的相互转化及其在反应介质中的溶解度差异是实现优异非对映选择性的关键。
    DOI:
    10.1246/cl.180275
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS<br/>[FR] COMPOSÉS, COMPOSITIONS ET PROCÉDÉS DE SYNTHÈSE
    申请人:WAVE LIFE SCIENCES LTD
    公开号:WO2018237194A1
    公开(公告)日:2018-12-27
    The present disclosure, among other things, provides technologies for synthesis, including reagents and methods for stereoselective synthesis. In some embodiments, the present disclosure provides compounds useful as chiral auxiliaries. In some embodiments, the present disclosure provides reagents and methods for oligonucleotide synthesis. In some embodiments, the present disclosure provides reagents and methods for chirally controlled preparation of oligonucleotides. In some embodiments, technologies of the present disclosure are particularly useful for constructing challenging internucleotidic linkages, providing high yields and stereoselectivity.
    本公开内容提供了合成技术,包括用于立体选择性合成的试剂和方法。在某些实施例中,本公开内容提供了作为手性辅助剂有用的化合物。在某些实施例中,本公开内容提供了用于寡核苷酸合成的试剂和方法。在某些实施例中,本公开内容提供了用于手性控制寡核苷酸制备的试剂和方法。在某些实施例中,本公开内容的技术特别适用于构建具有挑战性的核苷酸间连接,提供高产率和立体选择性。
  • Reductions, Reductive Alkylations, and Intramolecular Cyclizations of Acyl Silanes with Samarium Diiodide or Tributyltin Hydride
    作者:Tsung-Hsun Chuang、Jim-Min Fang、Weir-Torn Jiaang、Yeun-Min Tsai
    DOI:10.1021/jo951980m
    日期:1996.1.1
    bearing other substituents such as a bromine atom and alkenyl, succinimide, and carbonyl groups, were prepared, and their reactions with samarium diiodide or tributylstannane were studied. The reactions of acyl silanes occurred in various manners such as reductions, reductive alkylations, intramolecular radical cyclizations, pinacol couplings, aldol reactions, and Tishchenko reactions, depending on the nature
    制备了包括脂肪族,芳香族和双酰基硅烷在内的一系列酰基硅烷,以及带有其他取代基(如溴原子和烯基,琥珀酰亚胺和羰基)的酰基硅烷,并使其与二碘化sa反应或三丁基锡烷进行了研究。取决于基材的性质和反应条件,酰基硅烷的反应以各种方式发生,例如还原,还原烷基化,分子内自由基环化,频哪醇偶联,醛醇缩合反应和季申科反应。通常将酰基硅烷还原而得到相应的α-甲硅烷基醇,而不转移甲硅烷基。实现了5-己烯丙基硅烷和1-silyl-1,5-pentanedione的分子内自由基环化反应,得到α-甲硅烷基环戊醇和1,2-环戊二醇衍生物,分别。在四氢呋喃中用二碘化sa处理时,在叔丁醇存在下,1-(三甲基甲硅烷基)-1,6-己二酮进行了频哪醇偶联反应,而在甲醇存在下进行了Tishchenko反应。1-甲硅烷基-1,5-戊二酮的Tishchenko反应得到δ-甲硅烷基-δ-内酯。用二碘化treating处理后,分别进行1-(三甲基甲硅烷基)-1
  • Synthesis and structure activity relationship of the first class of LXR inverse agonists
    作者:Bahaa Elgendy、Kristine Griffett、Lamees Hegazy、Paolo Di Fruscia、Kirby Sample、Emmalie Schoepke、Theodore M. Kamenecka、Thomas P. Burris
    DOI:10.1016/j.bioorg.2021.105540
    日期:2022.2
    anticancer activity of SR9243 (7) and this suggests that new inverse agonists have great potential as anticancer agents. We identified compounds with distinct selectivity toward both LXR isoforms, which can be excellent tools to study the pharmacology of both isoforms. We employed molecular dynamic (MD) simulations to better understand the molecular mechanism underlying inverse agonist activity and to
    肝 X 受体 (LXR) 是核受体家族的成员,它们在脂质和胆固醇代谢中发挥重要作用。此外,它们是几种炎症途径的关键调节剂。LXRs 的药理调节在治疗代谢疾病、神经退行性疾病和癌症方面具有巨大潜力。我们是第一组鉴定出 LXR 反向激动剂 SR9238 ( 6 ) 和 SR9243 ( 7 ) 并证明了它们在治疗肝病和癌症方面的潜在效用。在这里,我们展示了基于 SR9238 ( 6 ) 和 SR9243 ( 7 ) 的结构-活性关系 (SAR) 研究结果。这项研究确定了16、17、19和38,它们是比 SR9238 ( 6 ) 和 SR9243 ( 7 ) 更有效的反向激动剂,并抑制 DU145 细胞中脂肪酸合酶基因的表达。我们之前证明了 FASN 的抑制与 SR9243 ( 7 ) 的抗癌活性相关,这表明新的反向激动剂具有作为抗癌剂的巨大潜力。我们鉴定了对两种 LXR 异构体具有不同选择性的
  • 9-Silafluorenyl Dichlorides as Chemically Ligating Coupling Agents and Their Application in Peptide Synthesis
    作者:Samuel J. Aspin、Sylvain Taillemaud、Patrick Cyr、André B. Charette
    DOI:10.1002/anie.201606120
    日期:2016.10.24
    A fundamentally simple, mild, and practical procedure for peptide bond formation is reported that employs a stoichiometric amount of easy‐to‐access 9‐silafluorenyl dichlorides as the coupling agent. Without initial preactivation or elaboration of the carboxylic acid or amine termini of the amino acids, the developed reagent is proposed to act through an unprecedented chemical ligation mechanism, bringing
    据报道,一种基本简单,温和且实用的肽键形成方法是采用化学计量的易于获得的9-二氟芴基二氯化物作为偶联剂。无需对氨基酸的羧酸或胺末端进行初步的预活化或精加工,就可以开发出一种通过空前的化学连接机制发挥作用的试剂,从而将两个偶联配偶体聚集在一起,然后再将其消除。因此以高收率和低至无差向异构化提供所需的酰胺或肽键。
  • Scalable anti-Markovnikov hydrobromination of aliphatic and aromatic olefins
    作者:Marzia Galli、Catherine J. Fletcher、Marc del Pozo、Stephen M. Goldup
    DOI:10.1039/c6ob00692b
    日期:——
    To improve access to a key synthetic intermediate we targeted a direct hydrobromination-Negishi route. Unsurprisingly, the anti-Markovnikov addition of HBr to estragole in the presence of AIBN proved successful. However, even in the absence of an added initiator, anti-Markovnikov addition was observed. Re-examination of early reports revealed that selective Markovnikov addition, often simply termed
    为了改善获得关键合成中间体的途径,我们的目标是直接进行氢溴化-根岸路线。毫不奇怪,在AIBN的存在下,将溴化氢在马齿中添加反马尔可夫尼可夫成功。然而,即使在没有添加引发剂的情况下,也观察到了反马尔科夫尼科夫的加入。对早期报道的重新检查表明,除非排除了空气,否则在溴化氢中并不总是观察到选择性马尔科夫尼科夫加法,通常简称为“正常”加法,导致重新发现了可重现且可扩展的无引发剂方案。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐